Description
An inhibitor of the FAFHA hydrolases AIG1 and ADTRP (IC50s = 0.57 and 8.5 µM, respectively); also inhibits ABHD6, LYPLA1, and LYPLA2; inhibits the FAHFA hydrolase activity of LNCaP and T cell lysates and intact cells
Formal name: 4-[2-(4-chlorophenyl)ethyl]-1-piperidinecarboxylic acid, 7-[4-(dimethylamino)benzoyl]hexahydro-1,3-dioxoimidazo[1,5-a]pyrazin-2-yl ester
Synonyms:
Molecular weight: 568.1
CAS: 1831135-30-8
Purity: ≥90%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Lipid Biochemistry|Fatty Acids